Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Cost of Goods Sold

Arbutus Biopharma Cp Cost of Goods Sold Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Cost of Goods Sold from 2010 to 2018.
  • Arbutus Biopharma Cp Cost of Goods Sold for the quarter ending December 12, 2018 was $-47m a 129.76% decrease of -61m year over year
  • Arbutus Biopharma Cp Cost of Goods Sold for the last 12 months ending September 09, 2018 was $65m a 3.12% increase of 2m year over year
  • Arbutus Biopharma Cp Annual Cost of Goods Sold for 2017 was $63m a 11.88% increase of 7m from 2016
  • Arbutus Biopharma Cp Annual Cost of Goods Sold for 2016 was $55m a 14.38% increase of 8m from 2015
  • Arbutus Biopharma Cp Annual Cost of Goods Sold for 2015 was $47m a 18.16% increase of 9m from 2014
Other Income Statement Metrics:
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Cost of Goods Sold Data

12/2018$-47m
09/2018$17m
06/2018$16m
03/2018$14m
12/2017$22m
09/2017$16m
06/2017$15m
03/2017$14m
12/2016$16m
09/2016$14m

Annual ABUS Cost of Goods Sold Data

2017$63m
2016$55m
2015$47m
2014$39m
2013$21m
2012$18m
2011$20m
2010$22m
2009$17m